Profil
Dr. Michael Häggman is an Independent Director at Prostatype Genomics AB, an Associate Professor-Urology at Uppsala University Hospital, a Deputy Director at Kardinaltalet AB and a General Partner at Skrotum Kommanditbolag.
He is on the Board of Directors at Prostatype Genomics AB and Chundsell Medicals AB.
Postes actifs de Michael Häggman
| Sociétés | Poste | Début |
|---|---|---|
| PROSTATYPE GENOMICS AB | Directeur/Membre du Conseil | 01/01/2018 |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Directeur/Membre du Conseil | - |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | - |
Skrotum Kommanditbolag | Corporate Officer/Principal | - |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Health Technology |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Prostatype Genomics AB
Prostatype Genomics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets prognostic genetic test prostatype equipment | Health Technology |
Skrotum Kommanditbolag |
















